Obesity and the Risk of Heart Failure
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Extreme obesity is recognized to be a risk factor for heart failure. It is unclear whether overweight and lesser degrees of obesity also pose a risk. METHODS: We investigated the relation between the body-mass index (the weight in kilograms divided by the square of the height in meters) and the incidence of heart failure among 5881 participants in the Framingham Heart Study (mean age, 55 years; 54 percent women). With the use of Cox proportional-hazards models, the body-mass index was evaluated both as a continuous variable and as a categorical variable (normal, 18.5 to 24.9; overweight, 25.0 to 29.9; and obese, 30.0 or more). RESULTS: During follow-up (mean, 14 years), heart failure developed in 496 subjects (258 women and 238 men). After adjustment for established risk factors, there was an increase in the risk of heart failure of 5 percent for men and 7 percent for women for each increment of 1 in body-mass index. As compared with subjects with a normal body-mass index, obese subjects had a doubling of the risk of heart failure. For women, the hazard ratio was 2.12 (95 percent confidence interval, 1.51 to 2.97); for men, the hazard ratio was 1.90 (95 percent confidence interval, 1.30 to 2.79). A graded increase in the risk of heart failure was observed across categories of body-mass index. The hazard ratios per increase in category were 1.46 in women (95 percent confidence interval, 1.23 to 1.72) and 1.37 in men (95 percent confidence interval, 1.13 to 1.67). CONCLUSIONS: In our large, community-based sample, increased body-mass index was associated with an increased risk of heart failure. Given the high prevalence of obesity in the United States, strategies to promote optimal body weight may reduce the population burden of heart failure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a study of 5,881 Framingham Heart Study participants, Kenchaiah et al. (30) showed that during a 14-year follow-up, for every 1 kg/m 2 increment in BMI, the risk of HF increased 5% in men and 7% in women.”
From Obesity and Cardiovascular Disease (2009) · cites this paper as [30]
In the citing paper
“In a study published in 1978, Wolf and colleagues reported that chronic AF not due to rheumatic heart disease was associated with a >5-fold excess risk of stroke,79 an observation that led them to call for “controlled trials of anticoagulation or antiarrhythmic agents in persons with chronic atrial fibrillation.””
From The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective (2014) · cites this paper as [79]
In the citing paper
“One of the most valuable clinical contributions from Framingham was the demonstration that non-rheumatic atrial fibrillation was a potent risk factor for stroke.”
From The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective (2014) · cites this paper as [79]
In the citing paper
“In the subset of patients who had echocardiography within 30 days of the heart failure diagnosis, the majority had reduced LV ejection fractions.”
From Cardiac remodeling in obesity (2008) · cites this paper as [173]
In the citing paper
“The main findings were that increased BMI was associated with an increased risk of heart failure in both men and women and that this risk was graded across categories of increasing BMI.”
From Cardiac remodeling in obesity (2008) · cites this paper as [173]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
The natural history of congestive heart failure: the Framingham study
McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852601 · Cited by 3,448
Self-citation(1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.4.899 · Cited by 2,700
The progression from hypertension to congestive heart failure
Levy, D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530440037034 · Cited by 2,155
Self-citationEpidemiological approaches to heart disease: the Framingham study
Dawber, T. R., Meadors, G. F., & Moore, F. E. (1951) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.41.3.279 · Cited by 2,148
Weight gain as a risk factor for clinical diabetes mellitus in women
Colditz, G. A., Willett, W. C., Rotnitzky, A., & Manson, J. E. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-7-199504010-00001 · Cited by 2,064
Hunt, S. A., Baker, D. W., Chin, M. H., Cinquegrani, M. P., Feldman, A. M., Francis, G. S., Ganiats, T. G., Goldstein, S., Gregoratos, G., Jessup, M. L., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01683-7 · Cited by 1,912
Obesity, Fat Distribution, and Weight Gain as Risk Factors for Clinical Diabetes in Men
Chan, J. M., Rimm, E. B., Colditz, G. A., Stampfer, M. J., & Willett, W. C. (1994) · Diabetes Care · doi:10.2337/diacare.17.9.961 · Cited by 1,808
Use and misuse of population attributable fractions
Rockhill, B., Newman, B., & Weinberg, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.1.15 · Cited by 1,683
Research works printed but not linked: 2
- 2000, World Health Organ Tech Rep Ser, 894, 1
- Alexander JK, 1963, Cardiovasc Res Cent Bull, 1, 39
Cited by
Items 301–400 of 1,010
Tsutamoto, T., Tanaka, T., Sakai, H., Ishikawa, C., Fujii, M., Yamamoto, T., & Horie, M. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm154 · Cited by 149
Statins and Pulmonary Fibrosis: The Potential Role of NLRP3 Inflammasome Activation
Xu, J.-F., Washko, G. R., Nakahira, K., Hatabu, H., Patel, A. S., Fernandez, I. E., Nishino, M., Okajima, Y., Yamashiro, T., Ross, J. C., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201108-1574oc · Cited by 141
Obesity paradox in elderly patients with cardiovascular diseases
Dorner, T. E., & Rieder, A. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.01.076 · Cited by 160
Dall, T. M., Zhang, Y., Chen, Y. J., Wagner, R. C. A., Hogan, P. F., Fagan, N. K., Olaiya, S. T., & Tornberg, D. N. (2007) · American Journal of Health Promotion · doi:10.4278/0890-1171-22.2.120 · Cited by 155
Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes
Fukushima, A., & Lopaschuk, G. D. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.03.020 · Cited by 153
Complications of obesity in adults: a short review of the literature.
Segula, D. (2014) · PubMed Central · Cited by 266
Metabolic syndrome and risk for heart failure in middle-aged men
Ingelsson, E., Ärnlöv, J., Lind, L., & Sundström, J. (2006) · Heart · doi:10.1136/hrt.2006.089011 · Cited by 155
Regional Body Composition Changes Exhibit Opposing Effects on Coronary Heart Disease Risk Factors
Okura, T., Nakata, Y., Yamabuki, K., & Tanaka, K. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000125702.26272.f6 · Cited by 140
“20 Criteria for CHD risk factors were defined as: (1) SBP 140 mm Hg; (2) DBP 90 mm Hg; (3) TC 220 mg/dL; (4) TG 150 mg/dL; (5) HDL-C 40 mg/dL; (6) LDL-C 140 mg/dL; (7) TC/HDL-C 5.”
MethodDiabetes Mellitus, the Renin-Angiotensin-Aldosterone System, and the Heart
Lim, H. S., MacFadyen, R. J., & Lip, G. Y. H. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.16.1737 · Cited by 138
Increased long-term mortality in heart failure due to sleep apnoea is not yet proven
Roebuck, T., Solin, P., Kaye, D. M., Bergin, P., Bailey, M., & Naughton, M. T. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00060404 · Cited by 138
In Search of Fewer Independent Risk Factors
Brotman, D. J. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.2.138 · Cited by 138
Gustafsson, F., Kragelund, C. B., Torp-Pedersen, C., Seibæk, M., Burchardt, H., Akkan, D., Thune, J. J., & Køber, L. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi022 · Cited by 137
Interdisziplinäre Leitlinie der Qualität S3 zur „Prävention und Therapie der Adipositas”
Hauner, H., Moss, A., Berg, A., Bischoff, S. C., Colombo‐Benkmann, M., Ellrott, T., Heintze, C., Kanthak, U., Kunze, D., Stefan, N., et al. (2014) · Adipositas - Ursachen Folgeerkrankungen Therapie · doi:10.1055/s-0037-1618857 · Cited by 205
“Besonders Adipositas 4/2014 © Schattauer 2014 204 gefährdet sind dabei Personen mit Begleiterkrankungen.”
BackgroundInfluentialIlkun, O. L., & Boudina, S. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319270003 · Cited by 147
Obesity Increases Risk‐Adjusted Morbidity, Mortality, and Cost Following Cardiac Surgery
Ghanta, R. K., LaPar, D. J., Zhang, Q., Devarkonda, V., Isbell, J. M., Yarboro, L. T., Kern, J. A., Kron, I. L., Speir, A. M., Fonner, C. E., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.003831 · Cited by 150
“In Framingham Heart Study participants, for every 1-unit increase in BMI, the risk of development of CHF increased by 5%.(21) Although obesity increases risk for development of cardiovascular disease, there are several studies that show that obese patients have a more favorable”
BackgroundBariatric surgery improves cardiac function in morbidly obese patients with severe cardiomyopathy
McCloskey, C. A., Ramani, G. V., Mathier, M. A., Schauer, P. R., Eid, G. M., Mattar, S. G., Courcoulas, A. P., & Ramanathan, R. C. (2007) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2007.05.006 · Cited by 138
Obesity and the Metabolic Syndrome
Keller, K. B., & Lemberg, L. (2003) · American Journal of Critical Care · doi:10.4037/ajcc2003.12.2.167 · Cited by 137
The Obesity Paradox and Heart Failure: A Systematic Review of a Decade of Evidence
Oga, E. A., & Eseyin, O. R. (2016) · Journal of Obesity · doi:10.1155/2016/9040248 · Cited by 131
Impact of Obesity in Critical Illness
Anderson, M. R., & Shashaty, M. G. S. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.08.001 · Cited by 147
“Obesity results in multiple cardiovascular changes including increased blood volume, stroke volume, and cardiac output; increased left ventricular (LV) and left atrial (LA) filling pressures; LV hypertrophy and LA enlargement; and increased risk for LV dysfunction.(51,52) These factors likely increase the risk of atri…”
Risk factors for heart failure
Kenchaiah, S., Narula, J., & Vasan, R. S. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.016 · Cited by 157
Self-citationDoes severe venous insufficiency have a different etiology in the morbidly obese? Is it venous?
Padberg, F. T., Cerveira, J. J., Lal, B. K., Pappas, P. J., Varma, S., & Hobson, R. W. (2003) · Journal of Vascular Surgery · doi:10.1067/mva.2003.61 · Cited by 134
Martin, B., Chen, G., Graham, M. M., & Quan, H. (2014) · BMC Health Services Research · doi:10.1186/1472-6963-14-70 · Cited by 141
“; licensee BioMed Central Commons Attribution License (http://creativec reproduction in any medium, provided the or part due to its impact on the cardiovascular system of these individuals [4-6].”
BackgroundPratley, R. E., Tuttle, K. R., Rossing, P., Rasmussen, S., Perkovic, V., Nielsen, O. W., Mann, J. F. E., MacIsaac, R. J., Kosiborod, M. N., Kamenov, Z., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.08.004 · Cited by 132
Polychlorinated biphenyls and links to cardiovascular disease
Perkins, J. T., Petriello, M. C., Newsome, B. J., & Hennig, B. (2015) · Environmental Science and Pollution Research · doi:10.1007/s11356-015-4479-6 · Cited by 139
“While atherosclerosis and hypertension are commonly associated with the development of CVD, obesity serves as a primary modulator of these conditions and has been implicated heavily in CVD development (Kenchaiah et al. 2002; Poirier et al. 2006; Van Gaal et al. 2006).”
Obesity and cardiovascular disease: an ESC clinical consensus statement
Koskinas, K. C., Craenenbroeck, E. M. V., Antoniades, C. A., Blüher, M., Gorter, T. M., Hanssen, H., Marx, N., McDonagh, T. A., Mingrone, G., Rosengren, A., et al. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae279 · Cited by 148
Chromium picolinate for reducing body weight: Meta-analysis of randomized trials
Pittler, M. H., Stevinson, C., & Ernst, E. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802262 · Cited by 131
Lavie, C. J., Milani, R. V., Ventura, H. O., Cardenas, G. A., Mehra, M. R., & Messerli, F. H. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.06.040 · Cited by 131
Oreopoulos, A., McAlister, F. A., Kalantar-Zadeh, K., Padwal, R., Ezekowitz, J. A., Sharma, A. M., Kovesdy, C. P., Fonarow, G. C., & Norris, C. M. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp288 · Cited by 131
“general population, a higher BMI is associated with an increased risk of coronary artery disease (CAD),(3) cardiovascular events,(3) and new-onset heart failure (HF).(4) This risk appears to be mediated through obesity-related co-morbidities such as diabetes mellitus, hypertension, and dyslipidaemia.”
BackgroundDietary Fat and Heart Failure: Moving From Lipotoxicity to Lipoprotection
Stanley, W. C., Dabkowski, E. R., Júnior, R. F. R., & O’Connell, K. A. (2012) · Circulation Research · doi:10.1161/circresaha.111.253104 · Cited by 141
Regional Adiposity and Heart Failure with Preserved Ejection Fraction
Rao, V. N., Fudim, M., Mentz, R. J., Michos, E. D., & Felker, G. M. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1956 · Cited by 131
Obesity and heart failure prognosis: paradox or reverse epidemiology?
Lavie, C. J., Mehra, M. R., & Milani, R. V. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi055 · Cited by 128
“In the current issue of the European Heart Journal, Gustafsson et al.8 present data which further suggest a protective influence of increasing BMI on subsequent mortality in 4700 patients hospitalized with HF.”
BackgroundInfluentialSIMONE, G. D., Devereux, R. B., Chinali, M., Best, L. G., Lee, E. T., Galloway, J. M., Resnick, H. E., & for the Strong Heart Study Investigators (2007) · Diabetes Care · doi:10.2337/dc06-2152 · Cited by 147
Pontiroli, A. E., Folli, F., Paganelli, M., Micheletto, G., Pizzocri, P., Vedani, P., Luisi, F., Perego, L., Morabito, A., & Bressani Doldi, S. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2703 · Cited by 129
“Obesity and type 2 diabetes are often complicated by arterial hypertension, a link that is allegedly mediated by increased sympathetic tone (16); left ventricular hypertrophy is found in longstanding obesity (4) and/or arterial hypertension (17) and is the supposed mechanism for congestive heart failure in obesity (18…”
BackgroundKapoor, J. R., & Heidenreich, P. A. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.10.026 · Cited by 143
“4) 30 (13) 50 (13) 40 (16) 7 (5) 7 (9.”
Weight loss and asthma control in severely obese asthmatic females
Maniscalco, M., Zedda, A., Faraone, S., Cerbone, M. R., Cristiano, S., Giardiello, C., & Sofia, M. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2007.07.029 · Cited by 141
Pandey, A., Patel, K. V., Bahnson, J. L., Gaussoin, S. A., Martin, C. K., Balasubramanyam, A., Johnson, K. C., McGuire, D. K., Bertoni, A. G., Kitzman, D., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044865 · Cited by 127
Obesity and Pulmonary Hypertension: A Review of Pathophysiologic Mechanisms
Friedman, S. E., & Andrus, B. W. (2012) · Journal of Obesity · doi:10.1155/2012/505274 · Cited by 135
“Obesity is a well-established risk factor for the development of heart failure with obesity, increasing the risk of incident congestive heart failure by two-fold or more [47, 48].”
BackgroundForouzanfar, M. H., Moran, A. E., Flaxman, A. D., Roth, G. A., Mensah, G. A., Ezzati, M., Naghavi, M., & Murray, C. J. L. (2012) · Global Heart · doi:10.1016/j.gheart.2012.10.003 · Cited by 138
“Average body mass index (over age 20 years) was included based on review of the literature [28].”
Obesity and Cardiovascular Disease
Obeng-Gyimah, E. K., & Sam, F. (2014) · Humana Press eBooks · doi:10.1007/978-1-62703-770-9_18 · Cited by 126
Lieb, W., Sullivan, L. M., Harris, T. B., Roubenoff, R., Benjamin, E. J., Levy, D., Fox, C. S., Wang, T. J., Wilson, P. W., Kannel, W. B., et al. (2009) · Diabetes Care · doi:10.2337/dc08-1596 · Cited by 127
“It is difficult to conclude from the positive relations of leptin to CHF incidence that leptin is an important mediator of disease (1) or whether higher levels are a compensatory response to underlying cardiac remodeling.”
BackgroundSelf-citationNovel Insights into the Cardio-Protective Effects of FGF21 in Lean and Obese Rat Hearts
Patel, V., Adya, R., Chen, J., Ramanjaneya, M., Bari, M. F., Bhudia, S. K., Hillhouse, E. W., Tan, B. K., & Randeva, H. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087102 · Cited by 124
“Indeed, it is well known that overweight and obese individuals have a significantly higher risk of developing coronary artery disease and some studies suggest that obese subjects fare poorly after a myocardial insult with higher morbidity and mortality [33,34]; equally there are numerous studies reporting that obese i…”
BackgroundMaruyama, Y., Mizuguchi, M., Yaginuma, T., Kusaka, M., Yoshida, H., Yokoyama, K., Kasahara, Y., & Hosoya, T. (2008) · Spinal Cord · doi:10.1038/sj.sc.3102171 · Cited by 135
Treatment of Patients With Atrial Fibrillation and Heart Failure With Reduced Ejection Fraction
Verma, A., Kalman, J. M., & Callans, D. J. (2017) · Circulation · doi:10.1161/circulationaha.116.026054 · Cited by 144
Ramani, G. V., McCloskey, C., Ramanathan, R. C., & Mathier, M. A. (2008) · Clinical Cardiology · doi:10.1002/clc.20315 · Cited by 123
Molecular and Cellular Basis for Diastolic Dysfunction
van Heerebeek, L., Franssen, C., Hamdani, N., Verheugt, F. W. A., Somsen, G. A., & Paulus, W. J. (2012) · Current Heart Failure Reports · doi:10.1007/s11897-012-0109-5 · Cited by 132
Perego, L., Pizzocri, P., Corradi, D., Maisano, F., Paganelli, M., Fiorina, P., Barbieri, M., Morabito, A., Paolisso, G., Folli, F., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1963 · Cited by 125
Insulin Resistance and Incident Heart Failure
Vardeny, O., Gupta, D. K., Claggett, B., Burke, S., Shah, A., Loehr, L., Rasmussen-Torvik, L., Selvin, E., Chang, P. P., Aguilar, D., et al. (2013) · JACC: Heart Failure · doi:10.1016/j.jchf.2013.07.006 · Cited by 117
“Obesity, known to be a primary determinant of insulin resistance, has also been independently associated with incident HF (6,7).”
BackgroundQin, F., Siwik, D. A., Luptak, I., Hou, X., Wang, L., Higuchi, A., Weisbrod, R. M., Ouchi, N., Tu, V. H., Calamaras, T. D., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.067801 · Cited by 122
“The polyphenols exert multiple effects in this model that may contribute to decreased myocardial hypertrophy and improved diastolic function including (1) a decrease in myocardial oxidative stress, (2) a decrease in oxidant-mediated protein modifications, (3) an improvement in hyperinsulinemia/insulin sensitivity, and…”
BackgroundNdumele, C. E., Matsushita, K., Sang, Y., Lazo, M., Agarwal, S. K., Nambi, V., Deswal, A. M., Blumenthal, R. S., Ballantyne, C. M., Coresh, J., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.017298 · Cited by 129
“Interestingly, NT-proBNP is inversely associated with BMI and known to be lower among obese individuals with and without HF, despite the higher burden of HF associated with obesity.(16,17) Multiple studies have demonstrated relatively poor correlation between natriuretic peptide levels and LV filling pressures among i…”
Adaptation and maladaptation of the heart in obesity
Harmancey, R., Wilson, C. R., & Taegtmeyer, H. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.110031 · Cited by 121
Effects of diet-induced obesity on inflammation and remodeling after myocardial infarction
Thakker, G. D., Frangogiannis, N. G., Bujak, M., Zymek, P., Gaubatz, J. W., Reddy, A. K., Taffet, G., Michael, L. H., Entman, M. L., & Ballantyne, C. M. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00322.2006 · Cited by 121
“Extreme obesity is known to impact the structure and function of the heart in terms of hemodynamic load, altered left ventricular (LV) remodeling, and impaired ventricular function leading to overt heart failure (30, 31).”
BackgroundInfluentialAbukhalil, M. H., Althunibat, O. Y., Aladaileh, S. H., Al‐Amarat, W., Obeidat, H. M., Al-khawalde, A. A.-M. A., Hussein, O. E., Alfwuaires, M. A., Algefare, A. I., Al‐Anazi, K. M., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111410 · Cited by 121
Long-term effects of weight-reducing diets in hypertensive patients
Siebenhofer, A., Jeitler, K., Berghold, A., Waltering, A., Hemkens, L. G., Semlitsch, T., Pachler, C., Strametz, R., & Horvath, K. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008274.pub2 · Cited by 120
Corey, K. E., & Kaplan, L. M. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.09.019 · Cited by 142
Mangner, N., Scheuermann, K., Winzer, E. B., Wagner, I. V., Hoellriegel, R., Sandri, M., Zimmer, M., Mende, M., Linke, A. H.-P., Kieß, W., et al. (2014) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2014.08.006 · Cited by 140
Cardiovascular Morbidity and Mortality of the Metabolic Syndrome
Obunai, K., Jani, S., & Dangas, G. (2007) · Medical Clinics of North America · doi:10.1016/j.mcna.2007.06.003 · Cited by 134
Mahajan, R., Stokes, M., Elliott, A., Munawar, D. A., Khokhar, K. B., Thiyagarajah, A., Hendriks, J., Linz, D., Gallagher, C., Kaye, D., et al. (2020) · Heart · doi:10.1136/heartjnl-2019-314770 · Cited by 116
Role of gender, age and BMI in prognosis of heart failure
Sciomer, S., Moscucci, F., Salvioni, E., Marchese, G., Bussotti, M., Corrà, U., & Piepoli, M. F. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487320961980 · Cited by 120
Impact of obesity on the risk of heart failure and survival after the onset of heart failure
Kenchaiah, S., Gaziano, J. M., & Vasan, R. S. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.011 · Cited by 135
Self-citationMagnani, J. W., Wang, N., Nelson, K. P., Connelly, S., Deo, R., Rodondi, N., Schelbert, E. B., Garcia, M. E., Phillips, C. L., Shlipak, M. G., et al. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.112.975342 · Cited by 137
Self-citationLong-term effects of weight-reducing diets in people with hypertension
Semlitsch, T., Jeitler, K., Berghold, A., Horvath, K., Posch, N., Poggenburg, S., & Siebenhofer, A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008274.pub3 · Cited by 118
Loehr, L. R., Rosamond, W. D., Poole, C., Marie McNeill, A., Chang, P. P., Folsom, A. R., Chambless, L. E., & Heiss, G. (2009) · Circulation: Heart Failure · doi:10.1161/circheartfailure.108.813782 · Cited by 115
Complementary therapies for reducing body weight: a systematic review
Pittler, M. H., & Ernst, E. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803008 · Cited by 121
Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart
Karmazyn, M., Purdham, D. M., Rajapurohitam, V., & Zeidan, A. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn115 · Cited by 118
Küpeli, S., Hazırolan, T., Varan, A., Akata, D., Alehan, D., Hayran, M., Besim, A., & Büyükpamukçu, M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.2627 · Cited by 117
Obesity and cardiovascular risk
Sharma, A. M. (2003) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(03)00047-9 · Cited by 134
Cuspidi, C., Rescaldani, M., Tadic, M., Sala, C., & Grassi, G. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpt215 · Cited by 118
Gaborit, B., Kober, F., Jacquier, A., Moro, P. J., Cuisset, T., Boullu, S., Dadoun, F., Alessi, M.-C., Morange, P., Clément, K., et al. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.117 · Cited by 116
A mathematical model for the burden of diabetes and its complications
Boutayeb, A., Twizell, E., Achouayb, K., & Chetouani, A. (2004) · BioMedical Engineering OnLine · doi:10.1186/1475-925x-3-20 · Cited by 119
“In the United States, obesity prevalence has increased from 30% in the sixties to more that 60% as indicated by a recent study on obesity and the risk of heart failure which considered hypertension, diabetes and myocardial infarction, stressing that obesity promotes all three, and these promote heart failure [8].”
BackgroundWannamethee, S. G., Shaper, A. G., Whincup, P. H., LENNON, L. T., & Sattar, N. A. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.057 · Cited by 119
“Our findings of a significant increase in the isk of HF associated with obesity and a trend toward ncreasing risk even in the overweight group are consistent ith those of other studies (2,4,5) and supports the possiility that both overweight and obesity are associated with ncreased risk of HF (4).”
ResultSarcomeric protein isoform transitions in cardiac muscle: A journey to heart failure
Yin, Z., Ren, J. T., & Guo, W. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.11.003 · Cited by 141
“Heart failure (HF) has been amajor public health focuswith an escalating health threat [1].”
Hafstad, A. D., Lund, J., Hadler‐Olsen, E., Höper, A. C., Larsen, T. S., & Aasum, E. (2013) · Diabetes · doi:10.2337/db12-1580 · Cited by 123
“Obesity, sedentary lifestyle, and reduced aerobic capacity are known predictors of heart failure and a major challenge to the health care system of the Western society (1,2).”
BackgroundEstimating the number of deaths due to obesity: can the divergent findings be reconciled?
Manson, J. E., Bassuk, S. S., Hu, F. B., Stampfer, M. J., Colditz, G. A., & Willett, W. C. (2007) · Journal of Women's Health · doi:10.1089/jwh.2006.0080 · Cited by 114
Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
Johnston, C. A., Moreno, J. P., & Foreyt, J. P. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0457-6 · Cited by 109
Obesity, Subclinical Myocardial Injury, and Incident Heart Failure
Ndumele, C. E., Coresh, J., Lazo, M., Hoogeveen, R. C., Blumenthal, R. S., Folsom, A. R., Selvin, E., Ballantyne, C. M., & Nambi, V. (2014) · JACC Heart Failure · doi:10.1016/j.jchf.2014.05.017 · Cited by 123
“Conditions closely linked to obesity, such as hypertension (HTN) and diabetes mellitus (DM), only partially explain the association between obesity and incident HF (4).”
Chien, S., Chandramouli, C., Lo, C., Lin, C., Sung, K., Huang, W., Lai, Y., Yun, C., Su, C., Yeh, H., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003661 · Cited by 120
Obesity-associated activation of angiotensin and endothelin in the cardiovascular system
Barton, M., Carmona, R., Ortmann, J., Krieger, J. E., & Traupe, T. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00307-2 · Cited by 126
Fang, L., Guo, F., Zhou, L., Stahl, R. D., & Grams, J. M. (2015) · Adipocyte · doi:10.1080/21623945.2015.1034920 · Cited by 129
“It is associated with an increased risk of type 2 diabetes mellitus, metabolic syndrome, cardiovascular disease, and cancer.(2-6) The mechanism by which obesity promotes dysmetabolism is not fully understood, but the literature implicates adipose tissue itself in the pathophysiology.”
BackgroundOlivier, A., Pitt, B., Girerd, N., Lamiral, Z., Machu, J.-L., McMurray, J. J. V., Swedberg, K., van Veldhuisen, D. J., Collier, T. J., Pocock, S. J., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.792 · Cited by 112
Shah, N. S., Molsberry, R., Rana, J. S., Sidney, S., Capewell, S., O’Flaherty, M., Carnethon, M., Lloyd-Jones, D. M., & Khan, S. S. (2020) · BMJ · doi:10.1136/bmj.m2688 · Cited by 113
The Obesity Paradox: Impact of Obesity on the Prevalence and Prognosis of Cardiovascular Diseases
Artham, S. M., Lavie, C. J., Milani, R. V., & Ventura, H. O. (2008) · Postgraduate Medicine · doi:10.3810/pgm.2008.07.1788 · Cited by 125
Bondareva, O., Rodríguez-Aguilera, J. R., Oliveira, F., Liao, L., Rose, A., Gupta, A., Singh, K., Geier, F., Schuster, J., Boeckel, J.-N., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00674-x · Cited by 111
Impact of General and Central Adiposity on Ventricular-Arterial Aging in Women and Men
Wohlfahrt, P., Redfield, M. M., Lopez-Jimenez, F., Melenovsky, V., Kane, G. C., Rodeheffer, R. J., & Borlaug, B. A. (2014) · JACC: Heart Failure · doi:10.1016/j.jchf.2014.03.014 · Cited by 111
“Obesity might produce hemodynamic alterations that predispose to changes in cardiac morphology and ventricular function (25) and is a potent independent risk factor for HF (1).”
BackgroundCatheter ablation for atrial fibrillation in patients with obesity
Cha, Y.-M., Friedman, P. A., Asirvatham, S. J., Shen, W.-K., Munger, T. M., Rea, R. F., Brady, P. A., Jahangir, A., Monahan, K. H., Hodge, D. O., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.716712 · Cited by 110
“Tamponade, n (%) 12 (2) 1 (1) 6 (3) 5 (2) 0.”
MethodImproving obesity and blood pressure
Tanaka, M. (2019) · Hypertension Research · doi:10.1038/s41440-019-0348-x · Cited by 122
Kruszewska, J., Cudnoch‐Jędrzejewska, A., & Czarzasta, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084195 · Cited by 127
Neurolipidomics: challenges and developments
Han, X. (2007) · Frontiers in Bioscience · doi:10.2741/2258 · Cited by 109
“, obesity, atherosclerosis, stroke, hypertension, and diabetes, which now are collectively referred to as the "metabolic syndrome" (5)) and neurodegenerative diseases (e.”
BackgroundEpigenetics and obesity cardiomyopathy: From pathophysiology to prevention and management
Zhang, Y., & Ren, J. T. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.03.005 · Cited by 115
Inflammation in Metabolic Cardiomyopathy
Wenzl, F. A., Ambrosini, S., Mohammed, S. A., Kraler, S. C., Lüscher, T. F., Costantino, S., & Paneni, F. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.742178 · Cited by 122
Impact of obesity on cardiac metabolism, fibrosis, and function
Mahajan, R., Lau, D. H., & Sanders, P. (2014) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2014.09.005 · Cited by 121
Aubin, M.-C., Lajoie, C., Clément, R., Gosselin, H., Calderone, A., & Perrault, L. P. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.135061 · Cited by 124
“Furthermore, in patients diagnosed with metabolic disorders, hypertension and coronary artery disease are prevalent and the subsequent risk of myocardial infarction is increased (Grundy et al., 2006; Kenchaiah et al., 2002; Klein et al., 2004).”
BackgroundRider, O. J., Tayal, U., Francis, J. M., Ali, M. K., Robinson, M. R., Byrne, J. P., Clarke, K., & Neubauer, S. (2010) · Obesity · doi:10.1038/oby.2010.64 · Cited by 108
Epidemiology of Heart Failure with Preserved Ejection Fraction
Andersson, C., & Vasan, R. S. (2014) · Heart Failure Clinics · doi:10.1016/j.hfc.2014.04.003 · Cited by 122
Self-citationNovel Metabolic Risk Factors for Heart Failure
Ingelsson, E., Ärnlöv, J., Sundström, J., Zethelius, B., Vessby, B. O., & Lind, L. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.07.059 · Cited by 117
Yamamoto, E., Dong, Y.-F., Kataoka, K., Yamashita, T., Tokutomi, Y., Matsuba, S., Ichijo, H., Ogawa, H., & Kim-Mitsuyama, S. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.112292 · Cited by 108
Perivascular Adipose Tissue as a Relevant Fat Depot for Cardiovascular Risk in Obesity
Costa, R. M., Neves, K. B., Tostes, R. C., & Lobato, N. S. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00253 · Cited by 107
“According to authors, approximately 11% of heart failure cases among men and 14% among women are attributable to obesity alone, suggesting that efforts to promote optimal body weight may reduce the risk of heart failure (Kenchaiah et al., 2002).”
BackgroundVivo, R. P., Krim, S. R., Çevik, C., & Witteles, R. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.037 · Cited by 109
Congestive heart failure in Latin America: the next epidemic
Cubillos-Garzón, L. A., Casas, J. P., Morillo, C. A., & Bautista, L. E. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.07.026 · Cited by 116
Güder, G., Frantz, S., Bauersachs, J. K., Allolio, B., Wanner, C., Koller, M., Ertl, G., Angermann, C. E., & Störk, S. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.825059 · Cited by 120
Modulation of Insulin Sensitivity by Exercise Training: Implications for Cardiovascular Prevention
Iaccarino, G., Franco, D., Sorriento, D., Strisciuglio, T., Barbato, E., & Morisco, C. (2021) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-020-10057-w · Cited by 106
Metadata
- Authors
- Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B., & Vasan, R. S.
- Affiliations
- Boston University (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-08
- Volume
- 347
- Issue
- 5
- Pages
- 305-313
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2017221955
- Cited by
- 3,093
- References
- 34
- Citations by year
- 2026: 79 · 2025: 144 · 2024: 156 · 2023: 139 · 2022: 135 · 2021: 144 · 2020: 180 · 2019: 123 · 2018: 115 · 2017: 130 · 2016: 146 · 2015: 137 · 2014: 149 · 2013: 153 · 2012: 136
- FWCI
- 52.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01hc25195-41-0-1)
- National Heart, Lung, and Blood Institute (N01‐HC25195, K24HL004334)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- obesity, heart failure, body mass index, overweight, heart failure risk, Framingham Heart Study, sex differences, incidence
- MeSH terms
- Echocardiography, Female, Heart Failure, Humans, Longitudinal Studies, Male, Middle Aged, Obesity, Risk Factors, Thinness, Body Mass Index, Incidence, Proportional Hazards Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.